homehome Home chatchat Notifications


The EU approves first-ever human Ebola vaccine for public use

At long last!

Alexandru Micu
November 13, 2019 @ 7:45 pm

share Share

The European Commission (the EU’s executive branch) has approved a functional Ebola vaccine, Ervbo, for human use. This is the first treatment of its kind to ever show efficacy in humans.

Image via Pixabay.

In an announcement on November 11, the European Commission granted Merck Sharp and Dohme B.V. marketing authorization for Ervebo in Europe. The European Medicines Agency, EMA, first recommended approval of the vaccine in October this year. A functional Ebola vaccine meant for human use has been a goal of the global research community ever since the massive outbreak in West Africa between 2014 and 2016.

A world first

This is the first time a vaccine for the disease that works in humans has been introduced for the dreadful disease. The Ebola virus can cause severe hemorrhagic fever, which involves both a rise in body temperature and massive internal bleeding from blood vessels throughout the body. The virus firsts attacks immune cells, which impairs our body’s early defenses. Eventually, macrophages do start striking back, but as they digest the virus, the cells release proteins that lead to the formation of small blood clots and inflammation, and cause leaks in your blood vessels. This is a very severe process that leads to a patient’s internal organs being starved for oxygen — around 90% of those infected by the virus die in this stage, according to the World Health Organization (WHO) Africa Region Office.

Until now, the only real way to protect yourself against Ebola was to avoid being contaminated — which is obviously hard in a full-blown outbreak. The only thing close to a functional vaccine for humans was a vaccine that worked in macaques, developed by researchers at the Public Health Agency of Canada’s National Microbiology Laboratory.

The new vaccine works by exposing patients to a form of the virus that can’t cause an infection. Our bodies can thus interact with the pathogen and learn how to fight it when the real virus comes around. It has been tested in an attempt to control Ebola outbreaks in the Democratic Republic of the Congo (DRC), showing great promise: the vaccine had an estimated protective efficacy of 97.5% in field studies. That’s a remarkable result in the best of conditions, and especially in the volatile conditions in the DRC, which is still struggling to recover from a series of civil wars.

Now that the European Commission has stamped its approval on the vaccine, there is a lot of interest that other regulatory bodies follow suit. The Food and Drug Administration (FDA) in the US is currently reviewing the vaccine for approval and could give the green light sometime in early 2020. However, Merck doesn’t expect the vaccine to make a lot of money: vaccines are, traditionally, not very lucrative, and Ebola is most prominent in poorer countries. The global health community might need to step in and support (i.e. fund) the use of the vaccine for it to reach as many of the people that need it as possible.

share Share

Scientists Say Junk Food Might Be as Addictive as Drugs

This is especially hurtful for kids.

A New AI Can Spot You by How Your Body Bends a Wi-Fi Signal

You don’t need a phone or camera to be tracked anymore: just wi-fi.

Golden Oyster Mushroom Are Invasive in the US. They're Now Wreaking Havoc in Forests

Golden oyster mushrooms, with their sunny yellow caps and nutty flavor, have become wildly popular for being healthy, delicious and easy to grow at home from mushroom kits. But this food craze has also unleashed an invasive species into the wild, and new research shows it’s pushing out native fungi. In a study we believe […]

The World’s Most "Useless" Inventions (That Are Actually Pretty Useful)

Every year, the Ig Nobel Prize is awarded to ten lucky winners. To qualify, you need to publish research in a peer-reviewed journal that is considered "improbable": studies that make people laugh and think at the same time.

This Ancient Greek City Was Swallowed by the Sea—and Yet Refused to Die

A 3,000-year record of resilience, adaptation, and seismic survival

Low testosterone isn't killing your libido. Sugar is

Small increases in blood sugar can affect sperm and sex, even without diabetes

NASA’s Parker Solar Probe Just Flew Closer to the Sun Than Ever Before and the Footage is Breathtaking

Closest-ever solar images offer new insights into Earth-threatening space weather.

The Oldest Dog Breed's DNA Reveals How Humans Conquered the Arctic — and You’ve Probably Never Heard of It

Qimmeq dogs have pulled Inuit sleds for 1,000 years — now, they need help to survive.

A Common DNA Sugar Just Matched Minoxidil in Hair Regrowth Tests on Mice

Is the future of hair regrowth hidden in 2-deoxy-D-ribose?

Your Personal Air Defense System Is Here and It’s Built to Vaporize Up to 30 Mosquitoes per Second with Lasers

LiDAR-guided Photon Matrix claims to fell 30 mosquitoes a second, but questions remain.